UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037474
Receipt number R000042720
Scientific Title Clinical study on pharyngeal retention of tea catechins
Date of disclosure of the study information 2019/07/31
Last modified on 2021/11/15 15:52:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study on pharyngeal retention of tea catechins

Acronym

Pharyngeal retention of tea catechins

Scientific Title

Clinical study on pharyngeal retention of tea catechins

Scientific Title:Acronym

Pharyngeal retention of tea catechins

Region

Japan


Condition

Condition

None

Classification by specialty

Pneumology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate local retention of pharyngeal and oral mucosa of tea catechins in humans

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Amount of catechins in the swabbing solution before and after the intake of the test product

Key secondary outcomes

Antiviral activity in the swabbing solution before and after the intake of the test product


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

1 day
57 mg tea catechins
once a day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

(1)Healthy adults between 20 and 65 years old
(2)Able to provide written informed consent
(3)Able to intake and gargle test product
(4)Able to write questionnaire

Key exclusion criteria

(1)Potentially having the allergy or side effects to tea-derived components
(2)Having injury or inflammation in the oral cavity or pharynx
(3)Being treated for liver, kidney, heart, respiratory, endocrine or metabolic, systemic immune, systemic infectious or other diseases
(4)Not able to stop taking food or supplements containing tea catechins
(5)Going to participate any clinical trial other than this study
(6)Judged as ineligible for this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Yamada

Organization

University of Shizuoka

Division name

School of Pharmaceutical Sciences

Zip code

422-8526

Address

52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan

TEL

+81-54-264-5762

Email

hyamada@u-shizuoka-ken.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Furushima

Organization

University of Shizuoka

Division name

School of Pharmaceutical Sciences

Zip code

422-8526

Address

52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan

TEL

+81-54-264-5591

Homepage URL

http://u-shizuoka-ken.ac.jp

Email

dfuru@u-shizuoka-ken.ac.jp


Sponsor or person

Institute

University of Shizuoka

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Kao Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Shizuoka Research Ethics Committee

Address

52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan

Tel

054-264-5103

Email

rinri@u-shizuoka-ken.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

花王株式会社 栃木事業場(栃木県)/ Kao Corporation Tochigi Plant


Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 07 Month 01 Day

Date of IRB

2019 Year 07 Month 01 Day

Anticipated trial start date

2019 Year 07 Month 25 Day

Last follow-up date

2019 Year 10 Month 01 Day

Date of closure to data entry

2019 Year 11 Month 30 Day

Date trial data considered complete


Date analysis concluded

2020 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2019 Year 07 Month 24 Day

Last modified on

2021 Year 11 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042720


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name